|
Cytomyx Holdings plc (AIM:CYX) is a rapidly growing life science company. It has two operating subsidiaries – Cytomyx Ltd based in Cambridge UK and Cytomyx LLC based in Lexington, MA, USA..
The Company provides a range of products and services that are used by its clients in the pharmaceutical industry to enhance their drug discovery productivity. These solutions enable clients to make better-informed decisions during drug development, through enhanced understanding of the role of gene and protein targets in disease progression and by being able to predict and eliminate drug candidates which might otherwise fail in late-stage development due to issues of toxicity or poor efficacy.
Cytomyx was formed in 1996 and is publicly listed on London's Alternative Investment Market.
To receive investor information and press releases as soon as they are available, join our email distribution list click here to contact us.
Annual Report and Accounts 2004
| 
Cytomyx Holdings Plc, 24-25 Signet Court, Cambridge, CB5 8LA, UK
